Dalbagni G - Search Results

1

Natural history of positive urinary cytology after radical cystectomy.

Raj GV, Bochner BH, Serio AM, Vickers A, Donat SM, Herr H, Lin O, Dalbagni G. Raj GV, et al. Among authors: dalbagni g. J Urol. 2006 Nov;176(5):2000-5; discussion 2005. doi: 10.1016/j.juro.2006.07.049. J Urol. 2006. PMID: 17070236

2

Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.

Sarkis AS, Dalbagni G, Cordon-Cardo C, Zhang ZF, Sheinfeld J, Fair WR, Herr HW, Reuter VE. Sarkis AS, et al. Among authors: dalbagni g. J Natl Cancer Inst. 1993 Jan 6;85(1):53-9. doi: 10.1093/jnci/85.1.53. J Natl Cancer Inst. 1993. PMID: 7677935

3

Association of P53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder.

Sarkis AS, Dalbagni G, Cordon-Cardo C, Melamed J, Zhang ZF, Sheinfeld J, Fair WR, Herr HW, Reuter VE. Sarkis AS, et al. Among authors: dalbagni g. J Urol. 1994 Aug;152(2 Pt 1):388-92. doi: 10.1016/s0022-5347(17)32745-3. J Urol. 1994. PMID: 8015077

4

Bladder cancer: advances in biology and treatment.

Bosl GJ, Fair WR, Herr HW, Bajorin DF, Dalbagni G, Sarkis AS, Reuter VE, Cordon-Cardo C, Sheinfeld J, Scher HI. Bosl GJ, et al. Among authors: dalbagni g. Crit Rev Oncol Hematol. 1994 Feb;16(1):33-70. doi: 10.1016/1040-8428(94)90041-8. Crit Rev Oncol Hematol. 1994. PMID: 8074800 Review.

5

Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer.

Zhang ZF, Sarkis AS, Cordon-Cardo C, Dalbagni G, Melamed J, Aprikian A, Pollack D, Sheinfeld J, Herr HW, Fair WR, et al. Zhang ZF, et al. Among authors: dalbagni g. Cancer Epidemiol Biomarkers Prev. 1994 Jan-Feb;3(1):19-24. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8118380

6

Clinical follow-up in 24 nonfamilial renal tumors cytogenetically characterized in tissue culture.

Golimbu M, Dalbagni G, Provet J, Comiter S, Morales P. Golimbu M, et al. Among authors: dalbagni g. Urology. 1994 Jan;43(1):26-30. doi: 10.1016/s0090-4295(94)80256-4. Urology. 1994. PMID: 8284882

7

Overexpression of p53 protein in a high-risk population of patients with superficial bladder cancer before and after bacillus Calmette-Guérin therapy: correlation to clinical outcome.

Lacombe L, Dalbagni G, Zhang ZF, Cordon-Cardo C, Fair WR, Herr HW, Reuter VE. Lacombe L, et al. Among authors: dalbagni g. J Clin Oncol. 1996 Oct;14(10):2646-52. doi: 10.1200/JCO.1996.14.10.2646. J Clin Oncol. 1996. PMID: 8874323

8

Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study.

Cookson MS, Sogani PC, Russo P, Sheinfeld J, Herr H, Dalbagni G, Reuter VE, Begg CB, Fair WR. Cookson MS, et al. Among authors: dalbagni g. Br J Urol. 1997 Mar;79(3):432-8. doi: 10.1046/j.1464-410x.1997.00022.x. Br J Urol. 1997. PMID: 9117227 Clinical Trial.

9

Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.

Dalbagni G, Han W, Zhang ZF, Cordon-Cardo C, Saigo P, Fair WR, Herr H, Kim N, Moore MA. Dalbagni G, et al. Clin Cancer Res. 1997 Sep;3(9):1593-8. Clin Cancer Res. 1997. PMID: 9815848

10

Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy.

Dalbagni G, Zhang ZF, Lacombe L, Herr HW. Dalbagni G, et al. Br J Urol. 1998 Dec;82(6):835-41. doi: 10.1046/j.1464-410x.1998.00878.x. Br J Urol. 1998. PMID: 9883221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters